Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Emberson

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Annals of Internal Medicine|August 13, 2019
General and Abdominal Adiposity and Mortality in Mexico City: A Prospective Study of 150 000 AdultsLouisa Gnatiuc, Jesus Alegre-Díaz, Rachel Wade, et al.
JAMA|May 10, 2012
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rateKunihiro Matsushita, Bakhtawar K Mahmoodi, Mark Woodward, et al.
BMC Public Health|December 31, 2024
Cognitive impairment at older ages among 8000 men and women living in Mexico City: a cross-sectional analyses of a prospective studyCarlos González-Carballo, Pablo Kuri-Morales, Erwin Chiquete, et al.
The Lancet. Public Health|November 1, 2024
Alcohol and mortality in Mexico: prospective study of 150 000 adultsEirini Trichia, Jesus Alegre-Díaz, Diego Aguilar-Ramirez, et al.
BMJ Open Diabetes Research & Care|March 8, 2023
Diabetes and infectious disease mortality in Mexico CityFiona Bragg, Pablo Kuri-Morales, Jaime Berumen, et al.
European Journal of Preventive Cardiology|November 13, 2025
Polygenic prediction of coronary heart disease among 130,000 Mexican adultsTianshu Liu, Jaime Berumen, Jason Torres, et al.
The Lancet. Diabetes & Endocrinology|October 13, 2025
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysisWilliam G Herrington, Zhaojing J Che, Rebecca Sardell, et al.
Eclinicalmedicine|July 21, 2025
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trialJunwen Zhou, Claire Williams, Natalie Staplin, et al.
Lancet (London, England)|July 18, 2020
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in EnglandMarion M Mafham, Enti Spata, Raphael Goldacre, et al.
The Lancet. Public Health|January 29, 2026
The effect of Indigenous American genomic ancestry on type 2 diabetes in Mexico: an analysis of 134 548 individuals from the Mexico City Prospective StudyJaime Berumen, Pablo Kuri-Morales, Jason M Torres, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Annals of Internal Medicine|August 13, 2019
General and Abdominal Adiposity and Mortality in Mexico City: A Prospective Study of 150 000 AdultsLouisa Gnatiuc, Jesus Alegre-Díaz, Rachel Wade, et al.
JAMA|May 10, 2012
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rateKunihiro Matsushita, Bakhtawar K Mahmoodi, Mark Woodward, et al.
BMC Public Health|December 31, 2024
Cognitive impairment at older ages among 8000 men and women living in Mexico City: a cross-sectional analyses of a prospective studyCarlos González-Carballo, Pablo Kuri-Morales, Erwin Chiquete, et al.
The Lancet. Public Health|November 1, 2024
Alcohol and mortality in Mexico: prospective study of 150 000 adultsEirini Trichia, Jesus Alegre-Díaz, Diego Aguilar-Ramirez, et al.
BMJ Open Diabetes Research & Care|March 8, 2023
Diabetes and infectious disease mortality in Mexico CityFiona Bragg, Pablo Kuri-Morales, Jaime Berumen, et al.
European Journal of Preventive Cardiology|November 13, 2025
Polygenic prediction of coronary heart disease among 130,000 Mexican adultsTianshu Liu, Jaime Berumen, Jason Torres, et al.
The Lancet. Diabetes & Endocrinology|October 13, 2025
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysisWilliam G Herrington, Zhaojing J Che, Rebecca Sardell, et al.
Eclinicalmedicine|July 21, 2025
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trialJunwen Zhou, Claire Williams, Natalie Staplin, et al.
Lancet (London, England)|July 18, 2020
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in EnglandMarion M Mafham, Enti Spata, Raphael Goldacre, et al.
The Lancet. Public Health|January 29, 2026
The effect of Indigenous American genomic ancestry on type 2 diabetes in Mexico: an analysis of 134 548 individuals from the Mexico City Prospective StudyJaime Berumen, Pablo Kuri-Morales, Jason M Torres, et al.
Pageof 8